SIRT6 and obesity disorder: A further challenge is understanding how the increased mono-ADP ribosyl-transferase, as in SIRT6 N308K/A313S overexpression in mature adipocytes, may reflect in ameliorated glucose metabolism in the context of obesity [74–76].